Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Beck

Showing results (1211-1220 of 1,428) with videos related to

Pageof 143
Sort By:
American Journal of Clinical Dermatology|May 3, 2022
Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic DermatitisLisa A Beck, Mette Deleuran, Robert Bissonnette, et al.
Eclinicalmedicine|July 23, 2025
Contemporary medical therapy, sex-specific characteristics, and outcomes of patients with non-ischemic cardiomyopathy: a prespecified interim analysis of the BIO-LIBRA studyValentina Kutyifa, Luigi Di Biase, Karthik Venkatesh Prasad, et al.
Aging & Mental Health|January 29, 2011
Implementing innovative models of dementia care: The Healthy Aging Brain CenterMalaz A Boustani, Greg A Sachs, Catherine A Alder, et al.
The Journal of Allergy and Clinical Immunology|September 8, 2009
Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticumPei-Song Gao, Nicholas M Rafaels, Tracey Hand, et al.
Cancer|September 21, 2019
Acceptance and commitment therapy for breast cancer survivors with fear of cancer recurrence: A 3-arm pilot randomized controlled trialShelley A Johns, Patrick V Stutz, Tasneem L Talib, et al.
The Journal of Investigative Dermatology|December 11, 2012
Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repairI-Hsin Kuo, Amanda Carpenter-Mendini, Takeshi Yoshida, et al.
Medrxiv : the Preprint Server for Health Sciences|July 10, 2023
At-Home High-Intensity Interval Training for Individuals with Paraplegia Following Spinal Cord Injury: A Pilot StudyMargaux B Linde, Kevin L Webb, Daniel D Veith, et al.
The Journal of Infectious Diseases|October 18, 2017
Prevalence of Pre-antiretroviral-Treatment Drug Resistance by Gender, Age, and Other Factors in HIV-Infected Individuals Initiating Therapy in Kenya, 2013-2014Rachel A Silverman, Ingrid A Beck, Catherine Kiptinness, et al.
PLOS Global Public Health|March 24, 2023
Implementation of an interactive mobile application to pilot a rapid assay to detect HIV drug resistance mutations in KenyaJustin D Vrana, Nuttada Panpradist, Nikki Higa, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 1, 2023
Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis: Results from a phase 2b, randomized, controlled trialEmma Guttman-Yassky, Jonathan I Silverberg, Diamant Thaçi, et al.
Pageof 143

Showing results (1211-1220 of 1,428) with videos related to

Sort By:
Pageof 143
American Journal of Clinical Dermatology|May 3, 2022
Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic DermatitisLisa A Beck, Mette Deleuran, Robert Bissonnette, et al.
Eclinicalmedicine|July 23, 2025
Contemporary medical therapy, sex-specific characteristics, and outcomes of patients with non-ischemic cardiomyopathy: a prespecified interim analysis of the BIO-LIBRA studyValentina Kutyifa, Luigi Di Biase, Karthik Venkatesh Prasad, et al.
Aging & Mental Health|January 29, 2011
Implementing innovative models of dementia care: The Healthy Aging Brain CenterMalaz A Boustani, Greg A Sachs, Catherine A Alder, et al.
The Journal of Allergy and Clinical Immunology|September 8, 2009
Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticumPei-Song Gao, Nicholas M Rafaels, Tracey Hand, et al.
Cancer|September 21, 2019
Acceptance and commitment therapy for breast cancer survivors with fear of cancer recurrence: A 3-arm pilot randomized controlled trialShelley A Johns, Patrick V Stutz, Tasneem L Talib, et al.
The Journal of Investigative Dermatology|December 11, 2012
Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repairI-Hsin Kuo, Amanda Carpenter-Mendini, Takeshi Yoshida, et al.
Medrxiv : the Preprint Server for Health Sciences|July 10, 2023
At-Home High-Intensity Interval Training for Individuals with Paraplegia Following Spinal Cord Injury: A Pilot StudyMargaux B Linde, Kevin L Webb, Daniel D Veith, et al.
The Journal of Infectious Diseases|October 18, 2017
Prevalence of Pre-antiretroviral-Treatment Drug Resistance by Gender, Age, and Other Factors in HIV-Infected Individuals Initiating Therapy in Kenya, 2013-2014Rachel A Silverman, Ingrid A Beck, Catherine Kiptinness, et al.
PLOS Global Public Health|March 24, 2023
Implementation of an interactive mobile application to pilot a rapid assay to detect HIV drug resistance mutations in KenyaJustin D Vrana, Nuttada Panpradist, Nikki Higa, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 1, 2023
Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis: Results from a phase 2b, randomized, controlled trialEmma Guttman-Yassky, Jonathan I Silverberg, Diamant Thaçi, et al.
Pageof 143